Carbon Bio
Expanding the reach of genetic medicines for devastating diseases
Boston, United States · Founded 2021
- Headquarters
- Boston, Massachusetts
- Employees
- 11–50
- Founded
- 2021
- Business Model
- B2B
- Website
- carbonbio.com
About
Carbon Biosciences is a pre-clinical stage biotechnology company developing genomic medicines through a proprietary platform leveraging novel parvovirus-derived gene therapy vectors. Founded in 2021 and headquartered in Boston, Massachusetts, the company launched with a $38 million Series A financing co-led by Longwood Fund and Agent Capital, with participation from UTokyo IPC (University of Tokyo Innovation Platform). Carbon Biosciences focuses on expanding the therapeutic potential of gene therapy for pulmonary and cardiac diseases, combining genetic diversity from naturally occurring viruses with modern clinical and manufacturing advances to develop durable genetic medicines.
Summary
Carbon Bio is a Biotech company based in Boston, United States, founded in 2021.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Specialty pharmaceutical company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/carbon-bio"><img src="https://indexed.vc/api/badge/company/carbon-bio" alt="Carbon Bio on Indexed.vc" width="260" height="76" /></a>